AR012476A1 - Derivados del 24-nor-secocola-5,7-dieno, su uso, procedimiento para prepararlos, composicion farmaceutica, y compuestos utiles como intermedios - Google Patents
Derivados del 24-nor-secocola-5,7-dieno, su uso, procedimiento para prepararlos, composicion farmaceutica, y compuestos utiles como intermediosInfo
- Publication number
- AR012476A1 AR012476A1 ARP980101809A ARP980101809A AR012476A1 AR 012476 A1 AR012476 A1 AR 012476A1 AR P980101809 A ARP980101809 A AR P980101809A AR P980101809 A ARP980101809 A AR P980101809A AR 012476 A1 AR012476 A1 AR 012476A1
- Authority
- AR
- Argentina
- Prior art keywords
- secocola
- intermediates
- derivatives
- prepare
- procedure
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000000543 intermediate Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 2
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 206010004146 Basal cell carcinoma Diseases 0.000 abstract 1
- 206010020649 Hyperkeratosis Diseases 0.000 abstract 1
- 201000002980 Hyperparathyroidism Diseases 0.000 abstract 1
- 208000001126 Keratosis Diseases 0.000 abstract 1
- 206010023439 Kidney transplant rejection Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 208000001647 Renal Insufficiency Diseases 0.000 abstract 1
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 230000003780 keratinization Effects 0.000 abstract 1
- 201000006370 kidney failure Diseases 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- -1 psoriasis Chemical class 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/88—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
- C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
- C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Abstract
Los derivados del 24-nor-secocola-5,7-dieno, de formula (I) en donde A es un enlace sencillo o un doble enlace, B es un grupo CH2CH2, CH=CH o C:::C, T esun grupo CH2 o CH2CH2, R1 y R3 son H o OH, C(R,R) es CH2 o C=CH2, R2 es CH3 y R4 es H, o R2 es H y R4 es CH3; L es fenilo y R5 es OH o C(alquilo de 1 a 4átomos de carbono)2OH, o L-R5 es 2-furilo que está sustituido en la posicion 5 con C(alquilo de 1 a 4 átomos de carbono)2OH, con la condicion de cuando L esfenilo, A es un enlace simple, Bes C:::C, T es CH2, cada R1 y R3 son OH, C(R,R) es C=CH2, R2 es CH3, R4 es H, y R5 es C(CH3)2OH, entonces R5 debe estaren la posicion orto o para, son de utilidad para el tratamiento o prevencion de trastornos que dependen de la vitamina D, particularmente psoriasis,carcinomas de las células basales, trastornos de la queratinizacion y queratosis, leucemia, osteoporosis, hiperparatiroidismo que acompana a lainsuficiencia renal, rechazo a un trasplante y la enfermedad del injerto frente al receptor, su uso; procedimiento para prepararlos; composicionesfarmacéuticas que los contienen; y compuestos utiles como intermedios para su preparacion.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97106547 | 1997-04-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012476A1 true AR012476A1 (es) | 2000-10-18 |
Family
ID=8226713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980101809A AR012476A1 (es) | 1997-04-21 | 1998-04-20 | Derivados del 24-nor-secocola-5,7-dieno, su uso, procedimiento para prepararlos, composicion farmaceutica, y compuestos utiles como intermedios |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6153605A (es) |
| EP (1) | EP0977734A2 (es) |
| JP (1) | JP2000511937A (es) |
| KR (1) | KR20010020132A (es) |
| CN (1) | CN1252791A (es) |
| AR (1) | AR012476A1 (es) |
| AU (1) | AU7523798A (es) |
| BR (1) | BR9809266A (es) |
| CA (1) | CA2287445A1 (es) |
| CO (1) | CO4950568A1 (es) |
| HR (1) | HRP980214A2 (es) |
| MA (1) | MA26481A1 (es) |
| PE (1) | PE69199A1 (es) |
| TR (1) | TR199902487T2 (es) |
| WO (1) | WO1998047866A2 (es) |
| ZA (1) | ZA983116B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000042008A1 (en) * | 1999-01-14 | 2000-07-20 | Solvay Pharmaceuticals B.V. | New vitamin d analogs |
| US6603030B1 (en) * | 1999-04-22 | 2003-08-05 | Hoffman-La Roche Inc. | Process for producing phosphineoxide vitamin D precursors |
| DE19935771A1 (de) | 1999-07-23 | 2001-02-01 | Schering Ag | Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
| WO2001051464A1 (en) | 2000-01-10 | 2001-07-19 | Leo Pharma A/S | Novel vitamin d analogues |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8929059D0 (en) * | 1989-12-22 | 1990-02-28 | Leo Pharm Prod Ltd | Chemical compounds |
| GB9007236D0 (en) * | 1990-03-30 | 1990-05-30 | Leo Pharm Prod Ltd | Chemical compounds |
| GB9017890D0 (en) * | 1990-08-15 | 1990-09-26 | Leo Pharm Prod Ltd | Chemical compounds i |
| WO1995017197A1 (en) * | 1993-12-23 | 1995-06-29 | The Regents Of The University Of California | Vitamin d3 analogues and pathway to mediate disorders |
| CA2175881A1 (en) * | 1995-05-09 | 1996-11-10 | Andrzej Kutner | Vitamin d compounds and methods of preparing these compounds |
| US5945410A (en) * | 1997-03-17 | 1999-08-31 | Wisconsin Alumni Research Foundation | 2-alkyl-19-nor-vitamin D compounds |
| US5843928A (en) * | 1997-03-17 | 1998-12-01 | Wisconsin Alumni Research Foundation | 2-alkylidene-19-nor-vitamin D compounds |
-
1998
- 1998-04-01 MA MA25020A patent/MA26481A1/fr unknown
- 1998-04-11 BR BR9809266-9A patent/BR9809266A/pt not_active Application Discontinuation
- 1998-04-11 EP EP98922685A patent/EP0977734A2/en not_active Withdrawn
- 1998-04-11 JP JP10544938A patent/JP2000511937A/ja active Pending
- 1998-04-11 AU AU75237/98A patent/AU7523798A/en not_active Abandoned
- 1998-04-11 CN CN98804354A patent/CN1252791A/zh active Pending
- 1998-04-11 TR TR1999/02487T patent/TR199902487T2/xx unknown
- 1998-04-11 KR KR1019997009685A patent/KR20010020132A/ko not_active Application Discontinuation
- 1998-04-11 WO PCT/EP1998/002116 patent/WO1998047866A2/en not_active Application Discontinuation
- 1998-04-11 CA CA002287445A patent/CA2287445A1/en not_active Abandoned
- 1998-04-14 ZA ZA983116A patent/ZA983116B/xx unknown
- 1998-04-16 US US09/061,381 patent/US6153605A/en not_active Expired - Fee Related
- 1998-04-17 PE PE1998000283A patent/PE69199A1/es not_active Application Discontinuation
- 1998-04-20 CO CO98021520A patent/CO4950568A1/es unknown
- 1998-04-20 AR ARP980101809A patent/AR012476A1/es unknown
- 1998-04-20 HR HR97106547.9A patent/HRP980214A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000511937A (ja) | 2000-09-12 |
| PE69199A1 (es) | 1999-07-10 |
| WO1998047866A2 (en) | 1998-10-29 |
| HRP980214A2 (en) | 1999-04-30 |
| CO4950568A1 (es) | 2000-09-01 |
| BR9809266A (pt) | 2000-06-27 |
| WO1998047866A3 (en) | 1999-02-25 |
| EP0977734A2 (en) | 2000-02-09 |
| US6153605A (en) | 2000-11-28 |
| MA26481A1 (fr) | 2004-12-20 |
| CA2287445A1 (en) | 1998-10-29 |
| AU7523798A (en) | 1998-11-13 |
| CN1252791A (zh) | 2000-05-10 |
| ZA983116B (en) | 1998-10-21 |
| KR20010020132A (ko) | 2001-03-15 |
| TR199902487T2 (xx) | 2001-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU51092A (sh) | Novi derivati tiopiranopirola i njihovo dobijanje | |
| ES2052550T3 (es) | 9-alfa-hidroxiesteroides, procedimiento para su preparacion y procedimiento para la preparacion de los correspondientes derivados 9(11)-deshidro. | |
| ES2193874B1 (es) | Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas. | |
| UY25204A1 (es) | Agonistas de prostaglandinas útiles en el tratamiento de desórdenes óseos | |
| UY26199A1 (es) | Nuevos derivados de benceno, un procedimiento para su preparación y las composiciones farmacéuticas que los contienen | |
| ECSP066667A (es) | Derivados de ciclohexano espirociclicos | |
| AR017967A1 (es) | Compuestos azapoliciclicos condensados con arilo, composiciones farmaceuticas de los mismos, su uso en la preparacion de medicamentos. | |
| AR062931A2 (es) | Compuestos que se enlazan a y activan un receptor de la trombopoyetina , composicones farmaceuticas que los contienen y su uso para la preparacion de medicamentos | |
| AR013494A1 (es) | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen | |
| ES2011210T3 (es) | Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| AR070540A1 (es) | Derivados de 6-oxo-5, 6-dihidro-benzo[c][1, 8]naftiridina, un proceso para su preparacion, un kit que los incluye y su uso en la fabricacion de medicamentos para el tratamiento del cancer. | |
| ES2036213T3 (es) | Procedimiento para preparar derivados tetrahidroisoquinolin-1-ilicos de acidos carboxilicos. | |
| AR012476A1 (es) | Derivados del 24-nor-secocola-5,7-dieno, su uso, procedimiento para prepararlos, composicion farmaceutica, y compuestos utiles como intermedios | |
| ES2115220T3 (es) | Nuevo uso de compuestos bis-heterociclicos como agentes antiinflamatorios y composiciones farmaceuticas de los mismos. | |
| AR125990A1 (es) | Intermediario novedoso para la preparación de piroxasulfona | |
| ECSP067028A (es) | Profármacos de esteroides con acción androgénica | |
| ZA825480B (en) | Novel androstane derivatives,processes for their manufacture and their use as medicaments | |
| ES506337A0 (es) | Procedimiento para la preparacion de derivados de guanidina | |
| AR013217A1 (es) | COMPUESTOS DERIVADOS DE 24a, 24b-DIHOMO-9,10-SECOCOLESTANO POLINSATURADO, SU USO, PROCEDIMIENTO PARA PREPARARLOS, COMPUESTOS UTILES COMO INTERMEDIARIOS,Y UNA COMPOSICION FARMACEUTICA QUE COMPRENDE DICHO COMPUESTO DERIVADO | |
| ZA87685B (en) | Phenylacetonitriles which are substituted by basic groups,their preparation and drugs containing these substances | |
| ES2039291T3 (es) | Procedimiento para la obtencion de 3-aminosidnoniminas substituidas y su empleo. | |
| CO5611104A2 (es) | Derivados azabiciclicos, azatriciciclos y azaespirociclicos de aminociclohexano como antagonistas de los receptores de nmda, 5ht3 y nicotinicos neuronales | |
| MX9303392A (es) | Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion. | |
| ES2038694T3 (es) | Procedimiento para la preparacion de los derivados de la 8-azaxantina alquilaminoalquil o heterociclilalquil sustituida en el anillo de triazol, asi como sales de la misma aceptables en la terapeutica. | |
| ES263931A1 (es) | Procedimiento de obtenciën de derivados de tiaxanteno |